Amgen Inc. buy Royal Bank of Canada
Start price
07.02.24
/
50%
€281.00
Target price
07.02.25
€305.58
Performance (%)
3.66%
Price
03.05.24
€289.20
Summary
This prediction is currently active. With a performance of 3.66%, the BUY prediction by Royal_Bank_of_Canada for Amgen Inc. is trending in the right direction. A total of €2.09 was paid as dividends for this prediction. This prediction currently runs until 07.02.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Amgen Inc. | 14.603% | 14.603% |
iShares Core DAX® | -0.922% | -1.993% |
iShares Nasdaq 100 | 0.371% | -0.868% |
iShares Nikkei 225® | 2.224% | -5.187% |
iShares S&P 500 | -0.026% | -0.918% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at Royal Bank of Canada from $303.00 to $329.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat